Category Archives: Top Market News
MongoDB (MDB) Receives a Rating Update from a Top Analyst
Monness analyst Brian White maintained a Buy rating on MongoDB (MDB – Research Report) today and set a price target of $190.00. The company’s shares closed last Monday at $131.01. According to TipRanks.com, White is a top 100 analyst with
Cowen & Co. Keeps Their Buy Rating on ImmunoGen (IMGN)
Cowen & Co. analyst Boris Peaker maintained a Buy rating on ImmunoGen (IMGN – Research Report) today. The company’s shares closed last Monday at $3.80. According to TipRanks.com, Peaker is a 3-star analyst with an average return of 1.2% and
Cellectar Biosciences (CLRB) Receives a Buy from H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Cellectar Biosciences (CLRB – Research Report) today and set a price target of $3.00. The company’s shares closed last Monday at $1.93. According to TipRanks.com, Ramakanth ‘s ranking currently consits
Ziopharm Oncology (ZIOP) Gets a Buy Rating from H.C. Wainwright
In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Ziopharm Oncology (ZIOP – Research Report), with a price target of $6.50. The company’s shares closed last Monday at $5.21. According to TipRanks.com, Ramakanth has
AC Immune SA (ACIU) Gets a Buy Rating from H.C. Wainwright
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on AC Immune SA (ACIU – Research Report) today and set a price target of $11.00. The company’s shares closed last Monday at $8.67. According to TipRanks.com, Fein is a 5-star
William Blair Sticks to Its Hold Rating for Bluebird Bio (BLUE)
In a report released today, Raju Prasad from William Blair maintained a Hold rating on Bluebird Bio (BLUE – Research Report). The company’s shares closed last Monday at $76.60, close to its 52-week low of $71.42. According to TipRanks.com, Prasad
